Performance of integrated positron emission tomography/computed tomography for mediastinal nodal staging in non-small cell lung carcinoma

Stephen R Broderick; G Alexander Patterson

doi:10.1016/j.thorsurg.2013.01.014

Performance of integrated positron emission tomography/computed tomography for mediastinal nodal staging in non-small cell lung carcinoma

Thorac Surg Clin. 2013 May;23(2):193-8. doi: 10.1016/j.thorsurg.2013.01.014. Epub 2013 Feb 19.

Authors

Stephen R Broderick¹, G Alexander Patterson

Affiliation

¹ Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, 3108 Queeny Tower, One Barnes-Jewish Hospital Plaza, St Louis, MO 63110-1013, USA. brodericks@wudosis.wustl.edu

PMID: 23566971
DOI: 10.1016/j.thorsurg.2013.01.014

Abstract

Integrated positron emission tomography (PET)/CT is routinely used for mediastinal nodal staging of non-small cell lung carcinoma in centers throughout the world. This modality is the most accurate noninvasive means by which to identify metastatic disease in mediastinal lymph nodes. This article reviews the evidence supporting the use of PET/CT and discusses the clinical applicability of this modality.

Publication types

Review

MeSH terms

Biopsy
Carcinoma, Non-Small-Cell Lung / diagnostic imaging*
Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / therapy
Humans
Lung Neoplasms / diagnostic imaging*
Lung Neoplasms / pathology
Lung Neoplasms / therapy
Lymph Nodes / diagnostic imaging*
Lymph Nodes / pathology
Lymphatic Metastasis
Mediastinum
Multimodal Imaging / methods*
Neoadjuvant Therapy
Neoplasm Staging
Positron-Emission Tomography*
Tomography, X-Ray Computed*